Publications
5674 Results
- Journal / Conference
- Blood 118(21):abstact 2004; American Society of Hematology, poster;
- Year
- 2011
- Research Committee(s)
- Myeloma
- Study Number(s)
- S0115
Modified high-dose melphalan and autologous stem cell transplantation (mHDM/SCT) in the treatment of AL amyloidosis (AL) and/or high-risk myeloma (hM): analysis of SWOG trial S0115
- Journal / Conference
- Blood 118(21):abstract 2594; American Society of Hematology, poster;
- Year
- 2011
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9030
Response to high dose cytarabine (HIDAC) as first salvage for relapsed acute lymphocytic leukemia is not affected by prior exposure to HIDAC
- Journal / Conference
- Blood 118(21):abstract 1446; American Society of Hematology, poster presentation;
- Year
- 2011
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0106, S0112, SWOG-9031, SWOG-9333, S9918
Prognostic import of French-American-British (FAB) system as embedded in 2008 revision of World Health Organization classification of AML
- Journal / Conference
- Blood 118(21):abstract 3516; American Society of Hematology, poster presenation;
- Year
- 2011
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9031, SWOG-9333, SWOG-9500
Prevalence and clinical implications of IDH1 R140 and R172 mutations in older adults with AML: a report from SWOG
- Journal / Conference
- Blood 118(21):abstract 83; American Society of Hematology Annual Meeting, oral presentation
- Year
- 2011
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
Late relapses following ALL-transretinoic acid for acute promyelocytic leukemia are uncommon, respond well to salvage therapy and occur independently of prognostic factors at diagnosis: longterm follow-up of North American Intergroup study 0129
- Journal / Conference
- Blood 118(21):abstract 1603; American Society of Hematology Annual Meeting, poster presenation
- Year
- 2011
- Research Committee(s)
- Lymphoma
- Study Number(s)
- E2496
Patterns of failure in patients with stage I/II bulky mediastinal hodgkins lymphoma (HL) treated with ABVD + radiotherapy or the Stanford V regimen in the randomized phase III North American Intergroup trial: E2496
- Journal / Conference
- BJU INTERNATIONAL 109:SUPPLEMENT 5, abst. 21, p.10; 10th International Kidney Cancer Symposium, poster presenation;
- Year
- 2011
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0931